[Using of aphobazol in the treatment of adaptation disorder in the contract service men, dismissed from the armed forces].
Litvintsev
S V
SV
Davydov
A T
AT
Uspenskiĭ
Iu P
IuP
Zagrebel'nyĭ
I A
IA
Balukova
E V
EV
D000223:Adaptation, Psychological / Q000187:drug effects*; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy* / Q000523:psychology; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008889:Military Personnel / Q000523:psychology*; D009025:Morpholines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome; D014478:Unemployment / Q000523:psychology*
C410924:2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole; D014151:Anti-Anxiety Agents; D001562:Benzimidazoles; D009025:Morpholines